Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses

Vaccine - Tập 30 - Trang 5099-5109 - 2012
Adam R. Spaulding1,2, Ying-Chi Lin3, Joseph A. Merriman1,2, Amanda J. Brosnahan1, Marnie L. Peterson3, Patrick M. Schlievert1,2
1Department of Microbiology, Medical School, University of Minnesota, Minneapolis, MN 55455, USA
2Department of Microbiology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA
3Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA

Tài liệu tham khảo

Lowy, 1998, Staphylococcus aureus infections, N Engl J Med, 339, 520, 10.1056/NEJM199808203390806 McCormick, 2001, Toxic shock syndrome and bacterial superantigens: an update, Annu Rev Microbiol, 55, 77, 10.1146/annurev.micro.55.1.77 Mulligan, 1993, Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management, Am J Med, 94, 313, 10.1016/0002-9343(93)90063-U Mylonakis, 2001, Infective endocarditis in adults, N Engl J Med, 345, 1318, 10.1056/NEJMra010082 Beynon, 2006, Infective endocarditis, BMJ, 333, 334, 10.1136/bmj.333.7563.334 Bayer, 1997, Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins, Infect Immun, 65, 4652, 10.1128/IAI.65.11.4652-4660.1997 Fowler, 2005, Staphylococcus aureus endocarditis: a consequence of medical progress, JAMA, 293, 3012, 10.1001/jama.293.24.3012 Miro, 2005, Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database, Clin Infect Dis, 41, 507, 10.1086/431979 Pragman, 2004, Characterization of virulence factor regulation by SrrAB, a two-component system in Staphylococcus aureus, J Bacteriol, 186, 2430, 10.1128/JB.186.8.2430-2438.2004 Xiong, 2006, Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis, J Infect Dis, 194, 1267, 10.1086/508210 Nienaber, 2008, Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins, J Infect Dis, 204, 704, 10.1093/infdis/jir389 Huseby, 2010, Beta toxin catalyzes formation of nucleoprotein matrix in staphylococcal biofilms, Proc Natl Acad Sci U S A, 107, 14407, 10.1073/pnas.0911032107 Cheung, 1994, Diminished virulence of a sar−/agr− mutant of Staphylococcus aureus in the rabbit model of endocarditis, J Clin Invest, 94, 1815, 10.1172/JCI117530 Spaulding, 2012, Comparison of Staphylococcus aureus strains for ability to cause infective endocarditis and lethal sepsis in rabbits, Front Cell Infect Microbiol, 2, 1, 10.3389/fcimb.2012.00018 Bubeck Wardenburg, 2007, Poring over pores: alpha-hemolysin and Panton–Valentine leukocidin in Staphylococcus aureus pneumonia, Nat Med, 13, 1405, 10.1038/nm1207-1405 Bubeck Wardenburg, 2008, Vaccine protection against Staphylococcus aureus pneumonia, J Exp Med, 205, 287, 10.1084/jem.20072208 Strandberg, 2010, Staphylococcal superantigens cause lethal pulmonary disease in rabbits, J Infect Dis, 202, 1690, 10.1086/657156 Voyich, 2006, Is Panton–Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease, J Infect Dis, 194, 1761, 10.1086/509506 Leder, 1998, A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II, J Exp Med, 187, 823, 10.1084/jem.187.6.823 Murray, 1996, Localization of biologically important regions on toxic shock syndrome toxin 1, Infect Immun, 64, 371, 10.1128/IAI.64.1.371-374.1996 Murray, 1994, Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1, J Immunol, 152, 87, 10.4049/jimmunol.152.1.87 Gaskin, 1997, Purification of Staphylococcus aureus beta-toxin: comparison of three isoelectric focusing methods, Protein Expr Purif, 9, 76, 10.1006/prep.1996.0664 Lin, 2011, Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus, Biochemistry, 50, 7157, 10.1021/bi200435n MacDonald, 1987, Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness, JAMA, 257, 1053, 10.1001/jama.1987.03390080043027 Schlievert, 2010, Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis, J Allergy Clin Immunol, 125, 39, 10.1016/j.jaci.2009.10.039 Schlievert, 1983, Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors, J Infect Dis, 147, 236, 10.1093/infdis/147.2.236 Schlievert, 1998, Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis, Infect Immun, 66, 218, 10.1128/IAI.66.1.218-223.1998 Blomster-Hautamaa, 1988, Preparation of toxic shock syndrome toxin-1, Methods Enzymol, 165, 37, 10.1016/S0076-6879(88)65009-9 Jardetzky, 1994, Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen, Nature, 368, 711, 10.1038/368711a0 McCormick, 2003, Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II/superantigen/TCR ternary complexes, J Immunol, 171, 1385, 10.4049/jimmunol.171.3.1385 Schlievert, 1982, Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C, Infect Immun, 36, 123, 10.1128/IAI.36.1.123-128.1982 Lee, 1991, Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins, Infect Immun, 59, 879, 10.1128/IAI.59.3.879-884.1991 Parsonnet, 1987, A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1, Infect Immun, 55, 1070, 10.1128/IAI.55.5.1070-1076.1987 Westphal, 1952, Uber die extraktion von vacterium mit phenol/wasser, Z Naturforsch, 7b, 148, 10.1515/znb-1952-0303 Schlievert, 1981, Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome, J Infect Dis, 143, 509, 10.1093/infdis/143.4.509 Peterson, 2005, Innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin-1, Infect Immun, 73, 2164, 10.1128/IAI.73.4.2164-2174.2005 Schlievert, 2007, Alpha and beta chains of hemoglobin inhibit production of Staphylococcus aureus exotoxins, Biochemistry, 46, 14349, 10.1021/bi701202w Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0 Roggiani, 2000, Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome, Infect Immun, 68, 5011, 10.1128/IAI.68.9.5011-5017.2000 Elgueta, 2009, Molecular mechanism and function of CD40/CD40L engagement in the immune system, Immunol Rev, 229, 152, 10.1111/j.1600-065X.2009.00782.x Wilson, 2011, A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia, PLoS Pathog, 7, e1002271, 10.1371/journal.ppat.1002271 Osterholm, 1982, Tri-state toxic-state syndrome study. I. Epidemiologic findings, J Infect Dis, 145, 431, 10.1093/infdis/145.4.431 Parsonnet, 2005, Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women, J Clin Microbiol, 43, 4628, 10.1128/JCM.43.9.4628-4634.2005 Vergeront, 1983, Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome, J Infect Dis, 148, 692, 10.1093/infdis/148.4.692 Kotb, 2002, An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections, Nat Med, 8, 1398, 10.1038/nm1202-800 Blomster-Hautamaa, 1986, Localization of biologic functions of toxic shock syndrome toxin-1 by use of monoclonal antibodies and cyanogen bromide-generated toxin fragments, J Immunol, 137, 3572, 10.4049/jimmunol.137.11.3572 Murphy, 1988, Localization of a biologically important epitope on toxic-shock-syndrome toxin-1, J Infect Dis, 158, 549, 10.1093/infdis/158.3.549 McCormick, 2000, Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome, J Immunol, 165, 2306, 10.4049/jimmunol.165.4.2306 Bergdoll, 1981, A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates, Lancet, 1, 1017, 10.1016/S0140-6736(81)92186-3 Huseby, 2007, Structure and biological activities of beta toxin from Staphylococcus aureus, J Bacteriol, 189, 8719, 10.1128/JB.00741-07 Sugawara-Tomita, 2002, Stochastic assembly of two-component staphylococcal gamma-hemolysin into heteroheptameric transmembrane pores with alternate subunit arrangements in ratios of 3:4 and 4:3, J Bacteriol, 184, 4747, 10.1128/JB.184.17.4747-4756.2002